Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural brain findings associated with clinical profiles but not diagnosis in unmedicated adults with obsessive-compulsive disorder: the Global OCD study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same author

The Earned Income Tax Credit and short-term changes in financial strain and drug use.

Health affairs scholar·2026
Same author

My Heart, My Self: an intensive longitudinal study examining the influence of intersectional discrimination on blood pressure.

BMC public health·2025
Same author

Epidemiology of Cannabis Use Among Middle-Aged and Older Adults in the U.S.

American journal of preventive medicine·2025
Same author

Detection of Diabetes and Hypertension Comorbidities Among Adult Psychiatric Inpatients.

The Journal of nervous and mental disease·2025
Same author

Concerted elevations of cortical and striatal glutamate and GABA in antipsychotic-free individuals at clinical high-risk for psychosis.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
See all related articles

Related Experiment Videos

Multiple indicator hidden Markov model with an application to medical utilization data.

Melanie M Wall1, Ran Li

  • 1Division of Biostatistics, School of Public Health, University of Minnesota, A460 Mayo Building, MMC 303, Minneapolis, MN 55455-0378, USA. melanie@biostat.umn.edu

Statistics in Medicine
|November 11, 2008
PubMed
Summary
This summary is machine-generated.

This study models alcoholism treatment effects using hidden Markov models (HMM). It found that a multiple indicator HMM better captures patient health states and medical visit patterns than simpler models.

Related Experiment Videos

Area of Science:

  • Biostatistics
  • Public Health
  • Epidemiology

Background:

  • Alcoholism significantly impacts healthcare utilization.
  • Understanding patient state transitions (healthy vs. unhealthy) is crucial for effective treatment.
  • Existing models may not fully capture the complexity of medical visit patterns related to alcoholism.

Purpose of the Study:

  • To model the impact of alcoholism treatment on patient health states.
  • To introduce and evaluate a multiple indicator hidden Markov model (HMM) for multivariate medical visit counts.
  • To compare the performance of the multiple indicator HMM against a univariate HMM and traditional longitudinal models.

Main Methods:

  • Utilized two-state hidden Markov models (HMM) to analyze monthly medical visit data.
  • Developed a multiple indicator HMM to simultaneously model multivariate Poisson counts of different medical visit types.
  • Employed a Bayesian framework for model estimation and WinBUGS for implementation.

Main Results:

  • The multiple indicator HMM effectively borrows information across various medical encounter types.
  • This approach provides a more nuanced understanding of patient states compared to a univariate HMM using total visit counts.
  • The proposed HMM demonstrated advantages over traditional longitudinal count models.

Conclusions:

  • The multiple indicator HMM is a powerful tool for analyzing complex healthcare utilization data in alcoholism research.
  • This model enhances the ability to track patient recovery and identify intervention needs.
  • Findings support the use of advanced statistical modeling for personalized alcoholism treatment strategies.